Hello,
We'll have a Geuvadis analysis group call today Oct 25th at 2pm CET.
Apologies for the late reminder.
On the agenda:
- ASHG poster
- analysis updates
- sQTL presentation from Jean
best,
Tuuli
Call details:
Germany +49 692 573 804 41 <tel:%2B49%20692%20573%20804%2041>
Netherlands +31 108 920 271 <tel:%2B31%20108%20920%20271>
Spain +34 931 816 661 <tel:%2B34%20931%20816%20661>
Sweden +46 840 309 949 <tel:%2B46%20840%20309%20949>
Switzerland +41 58 262 07 22 <tel:%2B41%2058%20262%2007%2022>
United Kingdom +44 203 370 57 19 <tel:%2B44%20203%20370%2057%2019>
United States +1 646 381 08 89 <tel:%2B1%20646%20381%2008%2089>
/Access code: 611683 /
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hello all,
I just wanted to thank all of you for material that you've sent me for
the main paper - now you can have a relaxed weekend while I have a huge
pile of stuff to read!
I'll be going through all the material during the next week, and I'll be
in touch with you if/when I need additional info.
By the way, there's a free presentation slot on the next TC if someone
wants to present.
best,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hi,
I've uploaded the cis-eQTL files for exons and miRNAs in
/upload/geuvadis/wp4_rnaseq/main_project/analysis_data/qtl/eQTL/ . The
wiki is outdated in terms of eQTL results, but the methods section
should be correct.
best,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hi all,
Here are the slides for the TC. I will present the results on splicing QTL
and some analysis on transcript variation if we have time.
Regards,
Jean
Dear GEUVADIS partners,
I would like to draw your attention to the petition from Anna Leptin. We highly encourage everybody to sign up and to forward it to colleagues at your institute and outside.
http://www.no-cuts-on-research.eu
Thanks
Best
Gabrielle
Gabrielle Bertier
Scientific Project Manager
International and Scientific Affairs
CRG, Center for Genomic Regulation
Carrer Dr. Aiguader, 88
08003 Barcelona, España
Tel: +34933160374
Mobile: +34639960656
email: gabrielle.bertier(a)crg.es<mailto:gabrielle.bertier@crg.es>
web: www.geuvadis.eu; www.fliact.eu
-----Original Message-----
From: Maria Leptin [mailto:maria.leptin@embo.org]
Sent: martes, 23 de octubre de 2012 02:13 p.m.
Subject: Please forward - Petition to protect EU science budget
Dear colleagues,
The discussions at the next summit of the European Union heads of state or government, which is scheduled for 22 and 23 November, will be decisive in determining the EU research budget for the next seven years. Several Member States are demanding severe cuts on the total EU budget and research will have to compete with other policy priorities.
This is a time when we, the scientific community, should act together and make our case to protect research funding, including that of the European Research Council (ERC), from cuts. Decisions will be prepared in discussions among politicians at the national level. All of us must look for opportunities to affect these decisions and send a strong signal to the heads of state or government.
An open letter signed by European Nobel laureates has been published in top European newspapers this week. The impact of this letter will be increased if it is followed by a mobilization of the national scientific communities. To keep the momentum going, an online petition has been launched:
http://www.no-cuts-on-research.eu
I would like to ask you to sign it and to encourage all your colleagues to do likewise. Note that in the past, less than 30 000 scientists signed the largest petition for a European scientific cause compared to the hundreds of thousands of signatures on petitions from other groups of society. We must do better than that.
This action is coordinated by the Initiative for Science in Europe (ise(a)i-se.org<mailto:ise@i-se.org>; www.initiative-science-europe.org<http://www.initiative-science-europe.org>), of which EMBO is a member. Please contact Wolfgang Eppenschwandtner, Executive Coordinator of the ISE if you have any questions or suggestions.
Best regards,
Maria Leptin
Director
EMBO - excellence in life sciences
Meyerhofstr. 1
69117 Heidelberg, Germany
tel +49-6221-8891-102
fax +49-6221-8891-202
maria.leptin(a)embo.org<mailto:maria.leptin@embo.org>
Hello all,
Here's some more info regarding the material that I've asked you to
contribute to the Geuvadis main paper.
The *deadline* for this was *today* but I'll extend it to next week's
*Friday, October 26*. Thanks to those couple of people who actually made
it on time. If you have some super-exciting additional analysis going on
beyond that date, send me the rest and write a placeholder of what's
missing.
*Text*: As I said before, everyone who wants to have their analysis
included in the main paper has to send me text that describes your
methods, results and conclusions. We will likely end up having a
supplementary text that is more than just methods, and I'll incorporate
your text there, and we'll of course use this information when writing
the main text.
- Think of this as a mini manuscript, so please write proper text with
full sentences. The text can and should be detailed, but don't overdo
it; include only relevant and interesting analyses/results.
- Refer to the figures/tables you provide with e.g. Fig.
TUULI_1_samplecorrelation (your name, figure number, description) so
that we can keep track of them. Write legends as well.
- Include references to the literature as PubMed IDs
*Figures*: The following has been written with plotting in R in mind -
you can of course use other software, but try to follow these guidelines
as much as possible. Nice figures are extremely important in making the
paper attractive to editors, reviewers and readers.
- 1-6 figures/tables per person is probably what we can include.
- size: height=5, width=5 inches. Make *sure* that the plots look good
when shrinked; they will be printed in max one column width which is
much much less than a powerpoint slide or your screen. If you deviate
from the square shape, keep in mind that most plots will be panels of a
single figure and should fit together.
- background must be white or transparent!
- axis labels, legends and all other text included in the plot *must *be
big enough. No exceptions. The default settings are hardly ever enough;
in R, cex.axis=1.5, cex.lab=1.5, cex.names=1.5 is good for 5x5 inch images.
- use the population and laboratory colors that have been defined in the
sample information sheet
- line width needs to be thick, 2 in most cases (lwd=2), e.g. in
boxplots, most scatterplots.
- save your figures as pdf vector graphic, in R the command is pdf() ,
with the file name like TUULI_1_samplecorrelation.pdf .
- have your scripts organized so that you can reproduce figures easily
if/when needed
Please let me know if you have any questions. These instructions will
hopefully save time and nerves from all of us, so that we can spend more
time thinking and discussing about science rather than figure formats.
cheers,
Tuuli (also known as the Figure Nazi...)
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all,
We will have a Geuvadis RNAseq workpackage call on Friday October 19th
at 4pm CET.
Agenda:
- Update on the analysis
- Outlines of the papers:
- main paper
- QC companion
- splicing companion
- loss-of-function companion
- Publication and authorship
- AOB
Call details:
Germany +49 692 573 804 41 <tel:%2B49%20692%20573%20804%2041>
Netherlands +31 108 920 271 <tel:%2B31%20108%20920%20271>
Spain +34 931 816 661 <tel:%2B34%20931%20816%20661>
Sweden +46 840 309 949 <tel:%2B46%20840%20309%20949>
Switzerland +41 58 262 07 22 <tel:%2B41%2058%20262%2007%2022>
United Kingdom +44 203 370 57 19 <tel:%2B44%20203%20370%2057%2019>
United States +1 646 381 08 89 <tel:%2B1%20646%20381%2008%2089>
/Access code: 611683
/People calling from CRG: Recently there have been some problems in
calling to the Spanish number above. The problem seems to be in your
end, and Gabrielle is checking what can be done. If it doesn't work,
please call e.g. to the German number.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hello,
We'll have a Geuvadis analysis group call on Thursday October 18th at
2pm CET.
On the agenda:
- analysis updates; in particular asQTLs and miRNA-mRNA interactions
- RNA editing presentation by Thomas
- if there's time, allele-specific alternative splicing slides by Tuuli
best,
Tuuli
Call details:
Germany +49 692 573 804 41 <tel:%2B49%20692%20573%20804%2041>
Netherlands +31 108 920 271 <tel:%2B31%20108%20920%20271>
Spain +34 931 816 661 <tel:%2B34%20931%20816%20661>
Sweden +46 840 309 949 <tel:%2B46%20840%20309%20949>
Switzerland +41 58 262 07 22 <tel:%2B41%2058%20262%2007%2022>
United Kingdom +44 203 370 57 19 <tel:%2B44%20203%20370%2057%2019>
United States +1 646 381 08 89 <tel:%2B1%20646%20381%2008%2089>
/Access code: 611683
/
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hello,
We'll have an analysis group call on Thursday October 11 at 2pm CET.
On the agenda:
- analysis updates
- figures for the main paper
- deadlines for the paper(s)
- splicing presentation by Micha
- allele-specific splicing presentation by Tuuli if there's time
Call details:
Germany +49 692 573 804 41 <tel:%2B49%20692%20573%20804%2041>
Netherlands +31 108 920 271 <tel:%2B31%20108%20920%20271>
Spain +34 931 816 661 <tel:%2B34%20931%20816%20661>
Sweden +46 840 309 949 <tel:%2B46%20840%20309%20949>
Switzerland +41 58 262 07 22 <tel:%2B41%2058%20262%2007%2022>
United Kingdom +44 203 370 57 19 <tel:%2B44%20203%20370%2057%2019>
United States +1 646 381 08 89 <tel:%2B1%20646%20381%2008%2089>
/Access code: 611683
/best,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hi,
here some updates on the analysis we've done on RNA editing:
http://sanabre.net/geuvadis/index.php/A2_Variant_Calling#Variant_calling_at…
Best Regards,
Thomas
--
Thomas Wieland Tel: +49 89 3187 2169
PhD Student Bioinformatics Fax: +49 89 3187 3297
Institute of Human Genetics
http://ihg.helmholtz-muenchen.de
Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstr. 1
85764 Neuherberg
www.helmholtz-muenchen.de
Aufsichtsratsvorsitzende: MinDir´in Bärbel Brumme-Bothe
Geschäftsführer: Prof. Dr. Günther Wess und Dr. Nikolaus Blum
Registergericht: Amtsgericht München HRB 6466
USt-IdNr: DE 129521671